ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value. Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.
| ICER highlighted in NCI Cancer Bulletin article on CER |
| Dr. Steven Pearson is quoted in the May 19, 2009 issue of the NCI Cancer Bulletin. |